SYRE
Spyre TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
SYRE vs peer average
32/100
SYRE vs. peer average (D vs. C)
Grade spread
A 2 · C 5 · D 3
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
SRPT is the first available peer comparator.
Rare-disease biotech with commercialization experience; useful comparator for regulatory and launch execution risk.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
SYRE
Spyre Therapeutics
SRPT
Sarepta Therapeutics
Grade
D
A
Momentum
96
31
Value
41
52
Sentiment
5
91
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs SRPT
SYRE / SRPT
Grade Position
Below peers
SYRE vs. peer average (D vs. C)
32/100
Momentum
96
SYREValue
41
SRPTSentiment
5
SRPTRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs SYRE
SRPT is the first peer returned for this comparison set.